Gene · 658
Papers1,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic Characteristics Associated With Aging in the Thyroid Gland. | Front Nutr | 2022 | 35694164 | PubTator, text mining | PubMed |
| Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years. | Front Cell Dev Biol | 2022 | 35693928 | PubTator, text mining | PubMed |
| Regulatory Role and Potential Importance of GDF-8 in Ovarian Reproductive Activity. | Front Endocrinol (Lausanne) | 2022 | 35692411 | PubTator, text mining | PubMed |
| Mechanisms during Osteogenic Differentiation in Human Dental Follicle Cells. | Int J Mol Sci | 2022 | 35682637 | PubTator, text mining | PubMed |
| Cell-Cell Contact Mediates Gene Expression and Fate Choice of Human Neural Stem/Progenitor Cells. | Cells | 2022 | 35681435 | PubTator, text mining | PubMed |
| The Emerging Role of Non-Coding RNAs in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells. | Front Cell Dev Biol | 2022 | 35652090 | PubTator, text mining | PubMed |
| miR-29a-5p Inhibits Prenatal Hair Placode Formation Through Targeting EDAR by ceRNA Regulatory Network. | Front Cell Dev Biol | 2022 | 35646897 | PubTator, text mining | PubMed |
| Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans. | Cell Biosci | 2022 | 35641992 | PubTator, text mining | PubMed |
| Musculoskeletal tissue engineering: Adipose derived stromal cell implementation for the treatment of osteoarthritis. | Biomaterials | 2022 | 35633592 | PubTator, text mining | PubMed |
| Description of Two New Cases of AQP1 Related Pulmonary Arterial Hypertension and Review of the Literature. | Genes (Basel) | 2022 | 35627312 | PubTator, text mining | PubMed |
| Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity? | Genes (Basel) | 2022 | 35627145 | PubTator, text mining | PubMed |
| Therapeutic Targeting the Allosteric Cysteinome of RAS and Kinase Families. | J Mol Biol | 2022 | 35595166 | PubTator, text mining | PubMed |
| Double-layer omics analysis of castration- and X-ray-resistant prostate cancer cells. | J Radiat Res | 2022 | 35589101 | PubTator, text mining | PubMed |
| Differences in the expression of DNA methyltransferases and demethylases in leukocytes and the severity of pulmonary arterial hypertension between ethnic groups. | Physiol Rep | 2022 | 35581740 | PubTator, text mining | PubMed |
Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells. | PLoS One | 2022 | 35580109 | PubTator, text mining | PubMed |
| Fractionated irradiation of MCF7 breast cancer cells rewires a gene regulatory circuit towards a treatment-resistant stemness phenotype. | Mol Oncol | 2022 | 35579852 | PubTator, text mining | PubMed |
| Small RNA sequencing and identification of papaya (Carica papaya L.) miRNAs with potential cross-kingdom human gene targets. | Mol Genet Genomics | 2022 | 35570207 | PubTator, text mining | PubMed |
| Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer. | Cells | 2022 | 35563856 | PubTator, text mining | PubMed |
| The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications. | Front Immunol | 2022 | 35558080 | PubTator, text mining | PubMed |
| Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells. | Oncoimmunology | 2022 | 35529675 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/658/papers?page=16